Related Articles
-
EGFR and K-RAS mutations and ERCC1, TUBB3, TYMS, RRM1 and EGFR mRNA expression in non‑small cell lung cancer: Correlation with clinical response to gefitinib or chemotherapy
-
Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy
-
Expression of ERCC1, TYMS, TUBB3, RRM1 and TOP2A in patients with esophageal squamous cell carcinoma: A hierarchical clustering analysis
-
Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study
-
Individualized chemotherapy guided by the expression of <em>ERCC1, RRM1, TUBB3, TYMS</em> and <em>TOP2A</em> genes versus classic chemotherapy in the treatment of breast cancer: A comparative effectiveness study